SITC 2016 Annual Meeting & Associated Programs
SITC 2016 Annual Meeting & Associated Programs

Society for Immunotherapy of Cancer (SITC)

2016 Annual Meeting & Associated Programs

Late-Breaking Abstract Information

Late-Breaking Abstracts Now Available

Abstracts for late-breaking submissions to SITC 2016 have now been published in the Journal for ImmunoTherapy of Cancer. Click one of the two following links to access the document.

Submission Period & Details

All late-breaking abstract submitters needed to submit an application during the Regular Abstract submission period, which ended August 8, 2016 at 11:59 p.m. EDT.

Late-breaking abstract submissions began on September 7 and closed on September 21, 2016 at 5 p.m. EDT and was only open to those who submitted an application.

Late-breaking abstract titles are now available via the SITC 2016 mobile app.

Late-Breaking Abstract Criteria & Eligibility

  • Late-Breaking Abstract submission is solely for abstracts with late-breaking data and not for abstracts submitted “late”. The late-breaking abstract deadline is not intended to be an extension of the general submission deadline.
  • Late-breaking abstracts highlight novel and practice-changing studies, and only apply to data that would have not otherwise have been presented as an abstract at the SITC 31st Annual Meeting.
  • Examples of acceptable late-breaking abstracts include the following (in each case, results were not available or significant by the Regular Abstract submission deadline):
    • Results of a practice-changing prospective Phase III clinical trial
    • Phase II study showing anti-tumor activity in a novel context
    • An early clinical trial with novel proof-of-principle data
    • Demonstration of novel cancer biology with therapeutic implications
  • For clinical studies, authors needed to justify late consideration by documenting the closure date of the study, and submit a Late-Breaking Abstract application by the Regular Abstract submission deadline (August 8, 2016). This application needed to include necessary abstract information (without results and conclusions) and incorporate the primary clinical endpoint for analysis, type of analysis, date of planned analysis, and planned statistical methods for analysis.
  • Laboratory-based studies needed to be justified within the author's Late-Breaking Abstract application. Authors needed to specify why experiments could not be completed before the standard abstract deadline.
  • The data in the abstract must not be published prior to the SITC 31st Annual Meeting.
2016 Annual Meeting
2016 Annual Meeting
2016 Annual Meeting
2016 Annual Meeting
2016 Annual Meeting

Important Dates

Thank You, Supporters!

Thank you, SITC 2016 supporters. Because of your generosity, SITC 2016 was a great success!

Interested in supporting other SITC programs? Confirm your support today!

Connect with SITC!

SITC: Join Today